
Dr. Reddy’s Launches Toripalimab in India, First Immuno-Oncology Drug for Nasopharyngeal Carcinoma
Dr. Reddy’s Laboratories Ltd has announced the launch of Toripalimab in India, marking a significant advancement in the treatment of nasopharyngeal carcinoma (NPC). Toripalimab, a New Biological Entity (NBE), is…












